Viemed Healthcare (VMD) Cost of Revenue (2018 - 2026)

Viemed Healthcare's Cost of Revenue history runs 9 years deep, the most recent figure standing at $32.6 million for Q1 2026.

• Quarterly Cost of Revenue rose 26.06% year-over-year to $32.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121.6 million (up 26.48% YoY) and the FY2025 annual result came in at $114.8 million, up 26.1% from the prior year.
• Cost of Revenue was $32.6 million for Q1 2026 at Viemed Healthcare, up from $32.1 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $32.6 million in Q1 2026 and bottomed at $12.5 million in Q1 2022.
• A 5-year average of $21.3 million and a median of $20.8 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue rose 17.22% — and 2024, when it soared 33.69%.
• Viemed Healthcare's Cost of Revenue stood at $14.6 million in 2022, then grew by 27.48% to $18.6 million in 2023, then soared by 31.83% to $24.6 million in 2024, then jumped by 30.63% to $32.1 million in 2025, then grew by 1.59% to $32.6 million in 2026.
• Business Quant data shows VMD's Cost of Revenue at $32.6 million in Q1 2026, $32.1 million in Q4 2025, and $30.6 million in Q3 2025.